Abstract
ANGIOGENESIS is required for a wide variety of physiological and pathological processes1. The endothelial cell-specific mitogen vascular endothelial growth factor (VEGF)2,3 is a major mediator of pathological angiogenesis4–6. Also, the expression of VEGF and its two receptors, Flt-1 and Flk-1/KDR, is related to the formation of blood vessels in mouse and rat embryos7–10. Mice homozygous for mutations that inactivate either receptor die in utero between days 8.5 and 9.5 (refs 11,12). However, ligand(s) other than VEGF might activate such receptors13,14. To assess the role of VEGF directly, we disrupted the VEGF gene in embryonic stem cells. Here we report the unexpected finding that loss of a single VEGF allele is lethal in the mouse embryo between days 11 and 12. Angiogenesis and blood-island formation were impaired, resulting in several developmental anomalies. Furthermore, VEGF-null embryonic stem cells exhibit a dramatically reduced ability to form tumours in nude mice.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
204,58 €
only 4,01 € per issue
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Folkman, J. & Shing, Y. J. biol. Chem. 267, 10931–10934 (1992).
Ferrara, N., Houck, K., Jakeman, L. & Leung, D. W. Endocr. Rev. 13, 18–32 (1992).
Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M. Am. J. Path. 146, 1029–1039 (1995).
Kim, K. J. et al. Nature 362, 841–844 (1993).
Adamis, A. P. et al. Am. J. Ophthalmol. 118, 445–450 (1994).
Aiello, L. P. et al. New Engl. J. Med. 331, 1480–1487 (1994).
Breier, G., Albrecht, U., Sterrer, S. & Risau, W. Development 114, 521–532 (1992).
Jakeman, L. B., Armanini, M., Phillips, H. S. & Ferrara, N. Endocrinology 133, 848–859 (1993).
Quinn, T., Peters, K. G., deVries, C., Ferrara, N. & Williams, L. T. Proc. natn. Acad. Sci. U.S.A. 90, 7533–7537 (1993).
Peters, K. G., deVries, C. & Williams, L. T. Proc. natn. Acad. Sci. U.S.A. 90, 8915–8919 (1993).
Fong, G.-H., Rossant, J., Gertenstein, M. & Breitman, M. Nature 376, 66–70 (1995).
Shalabi, F. et al. Nature 376, 62–66 (1995).
Park, J. E., Chen, H., Winer, J., Houck, K. A. & Ferrara, N. J. biol. Chem. 269, 25646–25654 (1994).
Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P. & Persico, M. G. Proc. natn. Acad. Sci. U.S.A. 88, 9267–9271 (1991).
Tisher, E. et al. J. biol. Chem. 266, 11947–11954 (1991).
Tybulewicz, V. L. J., Crawford, C. E., Jackson, P. K., Bronson, R. T. & Mulligan, R. C. Cell 65, 1153–1163 (1991).
Vigon, I. M. et al. Proc. natn. Acad. Sci. U.S.A. 89, 5640–5644 (1992).
Risau, W. et al. Development 102, 471–478 (1988).
Hilberg, F. & Wagner, E. F. Oncogene 7, 2371–2380 (1992).
Pugh, R. B. C. Pathology of the Testis (Blackwell, Oxford, 1976).
Hogan, B., Beddington, R., Constantini, F. & Lacy, E. Manipulating the Mouse Embryo 2nd edn (Cold Spring Harbor Laboratory Press, NY, 1994).
Bradley, A. in Teratocarcinoma and Embryonic Stem Cells: A Practical Approach (ed. Robertson, E. G.) 113–152 (ERL, Oxford, 1987).
Theiler, K. The House Mouse. Atlas of Embryonic Development (Springer, New York, 1989).
Brandon, E. P., Idzerda, R. L. & McKnight, G. S. Curr. Biol. 5, 625–634 (1995).
McBride, W. G. Lancet ii, 1358–1364 (1987).
D'Amato, R. J., Loughnan, M. S., Flynn, E. & Folkman, J. Proc. natn. Acad. Sci. U.S.A. 91, 4082–4085 (1994).
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning, a Laboratory Manual 2nd edn (Cold Spring Harbor Laboratory Press, NY, 1989).
Mansour, S. L., Thomas, K. R. & Capecchi, M. R. Nature 336, 348–352 (1988).
Mortensen, R. M., Conner, D. A., Chao, S., Geisterfer-Lowrance, A. A. & Seldman, J. G. Molec. cell. Biol. 12, 2391–2395 (1992).
Lu, L. H. & Gillett, N. Cell Vision 1, 169–176 (1994).
Author information
Affiliations
Rights and permissions
About this article
Cite this article
Ferrara, N., Carver-Moore, K., Chen, H. et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439–442 (1996). https://doi.org/10.1038/380439a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/380439a0
Further reading
-
Fibrin-based factor delivery for therapeutic angiogenesis: friend or foe?
Cell and Tissue Research (2022)
-
Vascular Endothelial Growth Factor Augments the Tolerance Towards Cerebral Stroke by Enhancing Neurovascular Repair Mechanism
Translational Stroke Research (2022)
-
Secretogranin III stringently regulates pathological but not physiological angiogenesis in oxygen-induced retinopathy
Cellular and Molecular Life Sciences (2022)
-
The migratory pathways of the cells that form the endocardium, dorsal aortae, and head vasculature in the mouse embryo
BMC Developmental Biology (2021)
-
Structure-activity relationships of natural quinone vegfrecine analogs with potent activity against VEGFR-1 and -2 tyrosine kinases
The Journal of Antibiotics (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.